Nevro

NVRO NYSE
64.32
+0.28
+0.44%
After Hours: 64.32 0 0.00% 16:30 06/25 EDT
Open
64.35
Prev Close
64.04
High
65.68
Low
63.80
Volume
353.72K
Avg Vol (3M)
452.24K
52 Week High
83.20
52 Week Low
34.75
% Turnover
1.16%
Market Cap
1.96B
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Nevro NVRO stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Nevro Corp. is a global medical device company. The Company focuses on providing products that improve the quality of life of patients suffering from chronic pain. The Company has developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. Its HF10 therapy is designed to deliver neuromodulation solutions for treating chronic pain. HF10 therapy enables patients to achieve sustained pain relief without paresthesia, thus enabling its patients to avoid the uncomfortable shocking or jolting sensations commonly associated with paresthesia. HF10 therapy relies on consistent anatomical lead placement. As of December 31, 2016, it was investigating the use of HF10 therapy to address additional indications, such as chronic upper limb and neck pain, painful neuropathies and non-surgical refractory back pain. The Senza system is approved to create electrical impulses from 2 hertz (Hz) to 10,000 Hz.
MORE >

Recently

Name
Price
%Change